Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Treon

Showing results (261-270 of 323) with videos related to

Pageof 33
Sort By:
American Journal of Hematology|April 5, 2021
Cell-free DNA analysis for detection of MYD88<sup>L265P</sup> and CXCR4<sup>S338X</sup> mutations in Waldenström macroglobulinemiaMaria G Demos, Zachary R Hunter, Lian Xu, et al.
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
The New England Journal of Medicine|August 31, 2012
MYD88 L265P somatic mutation in Waldenström's macroglobulinemiaSteven P Treon, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Lenalidomide and rituximab in Waldenstrom's macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Future Oncology (London, England)|February 23, 2023
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemiaChristian Buske, Alessandra Tedeschi, Judith Trotman, et al.
Blood|January 25, 2008
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemiaAllen W Ho, Evdoxia Hatjiharissi, Bryan T Ciccarelli, et al.
Haematologica|March 31, 2018
<i>MYD88</i> mutated and wild-type Waldenström's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in <i>CXCR4</i>Maria Luisa Guerrera, Nickolas Tsakmaklis, Lian Xu, et al.
Blood|November 5, 2008
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemiaXavier Leleu, Lian Xu, Xiaoying Jia, et al.
Haematologica|October 21, 2016
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndromeMonique C Minnema, Eva Kimby, Shirley D'Sa, et al.
Clinical Lymphoma & Myeloma|June 27, 2006
CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disordersDaniel Ditzel Santos, Evdoxia Hatjiharissi, Olivier Tournilhac, et al.
Pageof 33

Showing results (261-270 of 323) with videos related to

Sort By:
Pageof 33
American Journal of Hematology|April 5, 2021
Cell-free DNA analysis for detection of MYD88<sup>L265P</sup> and CXCR4<sup>S338X</sup> mutations in Waldenström macroglobulinemiaMaria G Demos, Zachary R Hunter, Lian Xu, et al.
Blood Advances|November 8, 2018
Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemiaZachary R Hunter, Lian Xu, Nickolas Tsakmaklis, et al.
The New England Journal of Medicine|August 31, 2012
MYD88 L265P somatic mutation in Waldenström's macroglobulinemiaSteven P Treon, Lian Xu, Guang Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Lenalidomide and rituximab in Waldenstrom's macroglobulinemiaSteven P Treon, Jacob D Soumerai, Andrew R Branagan, et al.
Future Oncology (London, England)|February 23, 2023
Plain Language Summary of the iNNOVATE study: ibrutinib plus rituximab is well-tolerated and effective in people with Waldenström's macroglobulinemiaChristian Buske, Alessandra Tedeschi, Judith Trotman, et al.
Blood|January 25, 2008
CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemiaAllen W Ho, Evdoxia Hatjiharissi, Bryan T Ciccarelli, et al.
Haematologica|March 31, 2018
<i>MYD88</i> mutated and wild-type Waldenström's Macroglobulinemia: characterization of chromosome 6q gene losses and their mutual exclusivity with mutations in <i>CXCR4</i>Maria Luisa Guerrera, Nickolas Tsakmaklis, Lian Xu, et al.
Blood|November 5, 2008
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemiaXavier Leleu, Lian Xu, Xiaoying Jia, et al.
Haematologica|October 21, 2016
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndromeMonique C Minnema, Eva Kimby, Shirley D'Sa, et al.
Clinical Lymphoma & Myeloma|June 27, 2006
CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's Macroglobulinemia and mast cell disordersDaniel Ditzel Santos, Evdoxia Hatjiharissi, Olivier Tournilhac, et al.
Pageof 33